Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziyun Liu

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Gastroenterology|March 16, 2024
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2<sup>+</sup> Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and ImmunotherapyYongjie Xie, Tianxing Zhou, Xueyang Li, et al.
Cancer Letters|December 22, 2024
The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinomaTianxing Zhou, Jingrui Yan, Bohang Xu, et al.
Gut|August 26, 2024
CD64<sup>+</sup> fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8<sup>+</sup> T cellsTianxing Zhou, Xupeng Hou, Jingrui Yan, et al.
Gut|February 24, 2023
SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradationJing Liu, Weiwei Bai, Tianxing Zhou, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 4, 2023
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axisTianxing Zhou, Yongjie Xie, Xupeng Hou, et al.
Cancer Discovery|March 27, 2026
Senescent cancer-associated fibroblasts drive early-stage lymph node metastasis in pancreatic cancer through lactate-mediated metabolic-epigenetic rewiringTianxing Zhou, Jingrui Yan, Guohua Mao, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Gastroenterology|March 16, 2024
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2<sup>+</sup> Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and ImmunotherapyYongjie Xie, Tianxing Zhou, Xueyang Li, et al.
Cancer Letters|December 22, 2024
The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinomaTianxing Zhou, Jingrui Yan, Bohang Xu, et al.
Gut|August 26, 2024
CD64<sup>+</sup> fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8<sup>+</sup> T cellsTianxing Zhou, Xupeng Hou, Jingrui Yan, et al.
Gut|February 24, 2023
SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradationJing Liu, Weiwei Bai, Tianxing Zhou, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 4, 2023
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axisTianxing Zhou, Yongjie Xie, Xupeng Hou, et al.
Cancer Discovery|March 27, 2026
Senescent cancer-associated fibroblasts drive early-stage lymph node metastasis in pancreatic cancer through lactate-mediated metabolic-epigenetic rewiringTianxing Zhou, Jingrui Yan, Guohua Mao, et al.
Pageof 6